1108-109 Low hemoglobin is an independent predictor of adverse fatal and nonfatal outcomes in both reduced and preserved systolic function chronic heart failure: Findings from the candesartan in heart failure assessment of reduction in mortality and morbidity program (CHARM)

McMurray, J. J. et al. (2004) 1108-109 Low hemoglobin is an independent predictor of adverse fatal and nonfatal outcomes in both reduced and preserved systolic function chronic heart failure: Findings from the candesartan in heart failure assessment of reduction in mortality and morbidity program (CHARM). Journal of the American College of Cardiology, 43(5), A197. (doi: 10.1016/s0735-1097(04)90836-4)

Abstract

No abstract available.

• Item Type: Articles
• Status: Published
• Refereed: Yes
• Glasgow Author(s) Enlighten ID: McMurray, Professor John
• Authors: McMurray, J. J., Lang, C. C., Swedberg, K., Östergren, J., Granger, C. B., Michelson, E., Young, J. B., Olofsson, B., Dunlap, M., Yusuf, S., and Pfeffer, M. A.
• College/School: College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health
• Journal Name: Journal of the American College of Cardiology
• Publisher: Elsevier Inc.
• ISSN: 0735-1097
• ISSN (Online): 1558-3597